588 related articles for article (PubMed ID: 19017470)
1. Engineering strategies to enhance nanoparticle-mediated oral delivery.
Yamanaka YJ; Leong KW
J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
[TBL] [Abstract][Full Text] [Related]
2. Challenges and advances in nanoparticle-based oral insulin delivery.
Ramesan RM; Sharma CP
Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
[TBL] [Abstract][Full Text] [Related]
3. Oral delivery of proteins by biodegradable nanoparticles.
Bakhru SH; Furtado S; Morello AP; Mathiowitz E
Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle strategies for the oral delivery of insulin.
Damgé C; Reis CP; Maincent P
Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
[TBL] [Abstract][Full Text] [Related]
5. The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems.
Sarparanta MP; Bimbo LM; Mäkilä EM; Salonen JJ; Laaksonen PH; Helariutta AM; Linder MB; Hirvonen JT; Laaksonen TJ; Santos HA; Airaksinen AJ
Biomaterials; 2012 Apr; 33(11):3353-62. PubMed ID: 22285465
[TBL] [Abstract][Full Text] [Related]
6. Targeted nanoparticles with novel non-peptidic ligands for oral delivery.
des Rieux A; Pourcelle V; Cani PD; Marchand-Brynaert J; Préat V
Adv Drug Deliv Rev; 2013 Jun; 65(6):833-44. PubMed ID: 23454185
[TBL] [Abstract][Full Text] [Related]
7. The performance of nanocarriers for transmucosal drug delivery.
Csaba N; Garcia-Fuentes M; Alonso MJ
Expert Opin Drug Deliv; 2006 Jul; 3(4):463-78. PubMed ID: 16822222
[TBL] [Abstract][Full Text] [Related]
8. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
9. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
Chen MC; Sonaje K; Chen KJ; Sung HW
Biomaterials; 2011 Dec; 32(36):9826-38. PubMed ID: 21925726
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules.
Chen MC; Mi FL; Liao ZX; Hsiao CW; Sonaje K; Chung MF; Hsu LW; Sung HW
Adv Drug Deliv Rev; 2013 Jun; 65(6):865-79. PubMed ID: 23159541
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle formulations in pulmonary drug delivery.
Bailey MM; Berkland CJ
Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
[TBL] [Abstract][Full Text] [Related]
12. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
Porter CJ; Pouton CW; Cuine JF; Charman WN
Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of nanoparticles for the treatment of lung diseases.
Azarmi S; Roa WH; Löbenberg R
Adv Drug Deliv Rev; 2008 May; 60(8):863-75. PubMed ID: 18308418
[TBL] [Abstract][Full Text] [Related]
14. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
15. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication.
Shahbazi MA; Santos HA
Curr Drug Metab; 2013 Jan; 14(1):28-56. PubMed ID: 22497568
[TBL] [Abstract][Full Text] [Related]
16. The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs.
Wang Y; Pi C; Feng X; Hou Y; Zhao L; Wei Y
Int J Nanomedicine; 2020; 15():6295-6310. PubMed ID: 32943863
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of drugs to the gastrointestinal tract.
Lavelle EC
Crit Rev Ther Drug Carrier Syst; 2001; 18(4):341-86. PubMed ID: 11605896
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of siRNA and antisense oligonucleotides.
Akhtar S
J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907
[TBL] [Abstract][Full Text] [Related]
19. Principles of transmucosal delivery of therapeutic agents.
Blanchette J; Kavimandan N; Peppas NA
Biomed Pharmacother; 2004 Apr; 58(3):142-51. PubMed ID: 15082336
[TBL] [Abstract][Full Text] [Related]
20. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles.
Samstein RM; Perica K; Balderrama F; Look M; Fahmy TM
Biomaterials; 2008 Feb; 29(6):703-8. PubMed ID: 18006053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
